Jørgen Fischer Ravn
Geen lopende functies
Profiel
Jørgen Fischer Ravn worked as a Partner at Reliance A and as VP-Investor Relations & Communications at Bionor Pharma ASA from 2015 to 2016.
Eerdere bekende functies van Jørgen Fischer Ravn
| Bedrijven | Functie | Einde |
|---|---|---|
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Investor Relations Contact | 01-09-2016 |
Reliance A/S
 Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Reliance A/S
Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
